One Barrier to Colorectal Cancer Screening Eliminated: On to the Next

Cancer Prev Res (Phila). 2022 Oct 4;15(10):641-644. doi: 10.1158/1940-6207.CAPR-22-0353.


Colorectal cancer screening is one of the best proven and most cost-effective of all preventive interventions. Screening lowers both incidence and mortality. Bearing some of the costs of colonoscopy, also known as cost-sharing, has been a barrier to completion of colonoscopy, both as a primary screen and as a second test to complete screening after an abnormal initial stool or radiologic screening test. While a newly published model concludes that eliminating cost-sharing for colonoscopy after an initial screen is cost-effective, the desired outcome has already been achieved. The Centers for Medicaid and Medicare Services has announced the plan to eliminate this final out of pocket expense starting in 2023. While this is an important step, many barriers to screening for colorectal cancer and all other cancers remain. Eliminating downstream costs that result from an abnormal screen is a difficult to achieve but important goal. See related article by Fendrick et al., p. 653.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aged
  • Colonoscopy
  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / prevention & control
  • Cost-Benefit Analysis
  • Deductibles and Coinsurance
  • Early Detection of Cancer* / economics
  • Follow-Up Studies
  • Humans
  • Mass Screening / economics
  • Medicare / economics
  • United States / epidemiology